Fredun Pharma Live Share Price Today, Share Analysis and Chart

Name: Fredun Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Fredun Pharmaceuticals Ltd.
Rating: 2.859833375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

Iran war impact

Based on the latest financial disclosures and annual reports as of March 2026, the impact of the ongoing conflict on Fredun Pharmaceuticals Ltd. is negative to moderate, primarily due to supply chain sensitivities and regional export exposure...

1724.55 8.35 (0.49%)

171.56% Gain from 52W Low

8,183

BSE Volume

BSE 02 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

68.1 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

No estimates available

Fredun Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Fredun Pharmaceuticals Ltd. worth buying?

37 Votes:

Buy 75.68%

Sell 16.22%

Hold 8.11%

Fredun Pharma Live Share Price Today, Share Analysis and Chart

Based on the latest financial disclosures and annual reports as of March 2026, the impact of the ongoing conflict on Fredun Pharmaceuticals Ltd. is negative to moderate, primarily due to supply chain sensitivities and regional export exposure...

171.56% Gain from 52W Low

SWOT Analysis

Fredun Pharma Live Price Chart